Matches in Wikidata for { <http://www.wikidata.org/entity/Q37326200> ?p ?o ?g. }
- Q37326200 description "2016 թվականի հոկտեմբերի 11-ին հրատարակված գիտական հոդված" @default.
- Q37326200 description "article científic" @default.
- Q37326200 description "article scientifique" @default.
- Q37326200 description "articolo scientifico" @default.
- Q37326200 description "artigo científico" @default.
- Q37326200 description "artículu científicu espublizáu en 2016" @default.
- Q37326200 description "bilimsel makale" @default.
- Q37326200 description "scientific article published on 11 October 2016" @default.
- Q37326200 description "vedecký článok" @default.
- Q37326200 description "vetenskaplig artikel" @default.
- Q37326200 description "videnskabelig artikel" @default.
- Q37326200 description "vědecký článek" @default.
- Q37326200 description "wetenschappelijk artikel" @default.
- Q37326200 description "wissenschaftlicher Artikel" @default.
- Q37326200 description "наукова стаття, опублікована в жовтні 2016" @default.
- Q37326200 description "научни чланак" @default.
- Q37326200 description "مقالة علمية نشرت في 11 أكتوبر 2016" @default.
- Q37326200 name "Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention" @default.
- Q37326200 name "Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention" @default.
- Q37326200 name "Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention" @default.
- Q37326200 type Item @default.
- Q37326200 label "Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention" @default.
- Q37326200 label "Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention" @default.
- Q37326200 label "Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention" @default.
- Q37326200 prefLabel "Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention" @default.
- Q37326200 prefLabel "Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention" @default.
- Q37326200 prefLabel "Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention" @default.
- Q37326200 P1433 Q37326200-54A7C234-8E67-4C6B-8ECF-4EF4D49D2859 @default.
- Q37326200 P1476 Q37326200-ECC3D98B-2244-4D9D-8012-FD9F4B357494 @default.
- Q37326200 P2093 Q37326200-001FBD4B-B51F-4329-8DF3-CEFDEEFC31EB @default.
- Q37326200 P2093 Q37326200-0200FEB4-D74D-4D3D-8B36-293530CDFB28 @default.
- Q37326200 P2093 Q37326200-0E8B5D15-097E-4920-A35E-3A587213C212 @default.
- Q37326200 P2093 Q37326200-42FB10A7-786A-426B-A0C4-1AEED25C4F31 @default.
- Q37326200 P2093 Q37326200-4F043783-761E-4B70-8440-C4972D70DA68 @default.
- Q37326200 P2093 Q37326200-4FF326F5-7D0C-4618-855D-67D43C140A0D @default.
- Q37326200 P2093 Q37326200-6520FCA2-4865-47AA-AA5B-6FAFC1DA09DA @default.
- Q37326200 P2093 Q37326200-7A29EFD8-A570-4C4C-8ADD-54F0DC9E4390 @default.
- Q37326200 P2093 Q37326200-7EE95D6A-6018-4976-9D56-ED1792E46C0A @default.
- Q37326200 P2093 Q37326200-90BA3EC9-4F37-488B-A722-DC3E12908D64 @default.
- Q37326200 P2093 Q37326200-9486BF62-7D6A-4E8D-A732-98E8A07E5448 @default.
- Q37326200 P2093 Q37326200-BC84845B-2888-4A9E-8F55-4558DBE9750C @default.
- Q37326200 P2093 Q37326200-C57F0167-AAAE-46C3-9E6D-1967C66B260D @default.
- Q37326200 P2093 Q37326200-D9CB7638-70CD-487C-B4E0-ADDE27AB6E27 @default.
- Q37326200 P2093 Q37326200-E006213A-46A8-451F-B7C8-D01C16381528 @default.
- Q37326200 P2093 Q37326200-EDCDE924-4D50-4D4C-8A57-A65B6F507D6D @default.
- Q37326200 P2093 Q37326200-F1F42448-5DEB-478A-9332-9D11FE1B3954 @default.
- Q37326200 P2093 Q37326200-F723BCD0-D33A-4529-8C6C-50639383BDDD @default.
- Q37326200 P2860 Q37326200-164B8163-C577-45BE-90BE-1F6C943583F7 @default.
- Q37326200 P2860 Q37326200-19D19A27-C4BC-43F1-9F66-5E025F83BCD3 @default.
- Q37326200 P2860 Q37326200-20D3873F-BBF2-4A7E-B3A3-08952B5AF1B0 @default.
- Q37326200 P2860 Q37326200-34FFFD67-76B6-43D8-B6DB-189AC02033A4 @default.
- Q37326200 P2860 Q37326200-3A92C562-15CB-45B8-99DA-ED8948B6321E @default.
- Q37326200 P2860 Q37326200-46E3890B-87BA-4185-9B6D-C34C7BE5C26C @default.
- Q37326200 P2860 Q37326200-494985D3-1978-48AF-B765-D8F6D7822D61 @default.
- Q37326200 P2860 Q37326200-555CBA7C-4632-42C8-B965-8ED0D78D1BAE @default.
- Q37326200 P2860 Q37326200-5AA8BE21-A325-4E8D-A5E4-F854B1F9F69E @default.
- Q37326200 P2860 Q37326200-5AF28651-C907-42E4-9B27-6697BF2B217E @default.
- Q37326200 P2860 Q37326200-6563964A-87C1-402C-B6D4-6476B92050C5 @default.
- Q37326200 P2860 Q37326200-6D660C2A-75A1-4276-B025-3669F64AEE0B @default.
- Q37326200 P2860 Q37326200-6E5F4C5A-1EF7-40A6-AAA3-666A915FD440 @default.
- Q37326200 P2860 Q37326200-7AB28621-055C-4606-892A-041544693D18 @default.
- Q37326200 P2860 Q37326200-83A288E6-647C-4936-9A8A-07CF972AFAE3 @default.
- Q37326200 P2860 Q37326200-975329EC-B012-4C20-9609-270C9EB455C5 @default.
- Q37326200 P2860 Q37326200-994D652C-3D46-4A4D-8771-8796078C3506 @default.
- Q37326200 P2860 Q37326200-9F83D569-1E46-4734-B9E1-CE13966F55A8 @default.
- Q37326200 P2860 Q37326200-A7A64DBF-DC43-4C0F-B946-86CA22F3E481 @default.
- Q37326200 P2860 Q37326200-AA3B4B48-528A-4237-BF20-D7F8B940A0CD @default.
- Q37326200 P2860 Q37326200-AC2C1571-9775-4573-9E9F-6C0B4C47CA4D @default.
- Q37326200 P2860 Q37326200-AD0B54DB-C532-4A80-AFF6-20BB84DDA705 @default.
- Q37326200 P2860 Q37326200-B3478C4B-5480-46FD-8E73-8C9BAD5AB172 @default.
- Q37326200 P2860 Q37326200-BCF60CB1-C5FF-4A45-9491-3BE609FDAE20 @default.
- Q37326200 P2860 Q37326200-CC30426C-A441-4A3E-BA6B-3C3A797A2DE4 @default.
- Q37326200 P2860 Q37326200-CCF32EBC-1864-4227-802B-AC242F4F8947 @default.
- Q37326200 P2860 Q37326200-D16AF740-F37A-4339-9D64-3CCDB95DEE68 @default.
- Q37326200 P2860 Q37326200-DAC329F9-293F-4B17-8198-D26F0BC5B6F9 @default.
- Q37326200 P2860 Q37326200-E93E74BB-E01F-4433-802A-EEE0C75A15A2 @default.
- Q37326200 P2860 Q37326200-F9E24C52-5D21-4D95-8EC6-24FBDAD35627 @default.
- Q37326200 P2888 Q37326200-20E22331-15D5-4BE5-9774-B64F4556EFA4 @default.
- Q37326200 P304 Q37326200-93EEE62A-0A30-49C8-A3D6-8978D5C7DA51 @default.
- Q37326200 P31 Q37326200-88F9193F-69D4-4F82-87A8-3D7C6EC6EE1F @default.
- Q37326200 P356 Q37326200-3F191F74-CDD0-40CA-8F37-48D65D4A3EE7 @default.
- Q37326200 P407 Q37326200-61B7734F-5882-48A9-9C6F-4D6C7BE7676F @default.
- Q37326200 P433 Q37326200-844DAA6E-D936-42B7-9D7C-3AC2C14B3BCB @default.
- Q37326200 P478 Q37326200-95B8E0CE-515B-45F3-A810-2C8641EE5738 @default.
- Q37326200 P577 Q37326200-B95B6313-5CC8-4B82-9843-EA031E95CE15 @default.
- Q37326200 P6179 Q37326200-BC955447-1BC5-408B-BAD8-7F3C879E8833 @default.
- Q37326200 P698 Q37326200-9F8C93D9-48CC-4D74-990F-0622729D92DB @default.
- Q37326200 P932 Q37326200-3211F29D-D895-4D90-945C-AE57EE4E735D @default.
- Q37326200 P356 S12933-016-0459-5 @default.
- Q37326200 P698 27729086 @default.
- Q37326200 P1433 Q2468083 @default.
- Q37326200 P1476 "Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention" @default.
- Q37326200 P2093 "Eiryu Sai" @default.
- Q37326200 P2093 "Hamad Al Shahi" @default.
- Q37326200 P2093 "Hiroshi Tamura" @default.
- Q37326200 P2093 "Hiroyuki Daida" @default.
- Q37326200 P2093 "Katsumi Miyauchi" @default.
- Q37326200 P2093 "Kazunori Shimada" @default.
- Q37326200 P2093 "Kikuo Isoda" @default.
- Q37326200 P2093 "Makoto Hiki" @default.